PhenomeX Inc. Common Stock
CELL
CELL was delisted on the 29th of September, 2023.
156 hedge funds and large institutions have $1.87B invested in PhenomeX Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 67 increasing their positions, 36 reducing their positions, and 36 closing their positions.
86% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 36
42% more call options, than puts
Call options by funds: $9.3M | Put options by funds: $6.57M
3% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 36
1% more funds holding
Funds holding: 155 → 156 (+1)
1% less capital invested
Capital invested by funds: $1.89B → $1.87B (-$14.5M)
57% less funds holding in top 10
Funds holding in top 10: 7 → 3 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$107M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$82.8M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$51.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$29.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SUT
SC US (TTGP)
Menlo Park,
California
|
-$61.6M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$48.6M |
| 3 |
CCM
Cota Capital Management
San Francisco,
California
|
-$39.6M |
| 4 |
CCM
CAAS Capital Management
New York
|
-$28M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$22.1M |
CELL Hedge Fund Activity: Q2 2021 in Review
156 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in PhenomeX Inc. Common Stock (CELL) for Q2 2021, worth a combined $1.87B — down 0.77% from $1.89B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new CELL positions and 36 closed out — a net gain of 1 holder — while 67 added to existing stakes and 36 trimmed.
The largest buyer was BlackRock, adding an estimated $107M. The largest seller was SC US (TTGP), cutting an estimated $61.6M.
- 156 institutional investors held PhenomeX Inc. Common Stock (CELL) as of Q2 2021, up from 155 in Q1 2021.
- Funds reported $1.87B of PhenomeX Inc. Common Stock stock for Q2 2021, down 0.77% quarter-over-quarter.
- 37 funds opened new PhenomeX Inc. Common Stock positions in Q2 2021 and 36 closed out, a net change of +1 holder.
- The largest PhenomeX Inc. Common Stock buyer in Q2 2021 was BlackRock, an estimated $107M added.
- The largest PhenomeX Inc. Common Stock seller in Q2 2021 was SC US (TTGP), an estimated $61.6M sold.
Based on aggregated 13F filings for Q2 2021.